<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03212378</url>
  </required_header>
  <id_info>
    <org_study_id>FA_2017_01</org_study_id>
    <nct_id>NCT03212378</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of &quot;Standardized&quot; CHIP</brief_title>
  <official_title>Safety and Efficacy of &quot;Standardized&quot; Complex High-risk Interventional Procedures - a New Pathway for Protected Percutaneous Coronary Interventions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Essen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Essen</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In routine clinical practice, high-risk patients with high-risk anatomies are more often
      referred for interventional treatment by percutaneous coronary interventions (PCI). Current
      guidelines only suggest that elective insertion of an appropriate hemodynamic support device
      as an adjunct to PCI may be reasonable in selected high-risk patients.

      The objective of this retrospective study is to investigate the safety and efficacy of a
      &quot;standardized program&quot; for complex high-risk interventional procedures (CHIP).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Anticipated">December 30, 2018</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Safety &amp; feasibility</measure>
    <time_frame>30 days</time_frame>
    <description>Accurate classification of patients into the respective group defined by the necessity of upgrade</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hemodynamic Compromise (HC)</measure>
    <time_frame>30 days.</time_frame>
    <description>Freedom from hemodynamic compromise during PCI procedure defined as: mean arterial pressure (MAP) not decreasing to values below 60 mmHg for more than 10 minutes during the PCI procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Cardiac and Cerebrovascular Events (MACCE)</measure>
    <time_frame>30 days</time_frame>
    <description>A composite rate of the following intra-procedural and post-procedural Major Adverse Cardiac and Cerebrovascular Events (MACCE) events defined as death, new myocardial infarction, or cerebrovascular accident up to 30 days post index procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>30 days</time_frame>
    <description>Rates of acute kidney injury ([AKI] according to KDIGO), sepsis, vascular complications (defined by Valve Academic Research Consortium 2 [VARC 2]), bleeding (defined by Bleeding Academic Research Consortium [BARC]) and coronary complications.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>CHIP 1 - low risk patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>CHIP 2 - medium risk patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>CHIP 3 - high risk patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>percutaneous coronary interventions</intervention_name>
    <description>Percutaneous coronary intervention.</description>
    <arm_group_label>CHIP 1 - low risk patients</arm_group_label>
    <arm_group_label>CHIP 2 - medium risk patients</arm_group_label>
    <arm_group_label>CHIP 3 - high risk patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population consists of consecutive high-risk subjects indicated for percutaneous
        complex high-risk interventional procedures.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed Informed Consent

          -  Non emergent PCI of at least one de novo or restenotic lesion in a native coronary
             vessel or bypass graft

        Exclusion Criteria:

          -  Subject has uncorrectable abnormal coagulation parameters (defined as platelet count
             ≤75,000/mm3 or INR ≥2.5.)

          -  History of recent (within 1 month) stroke or TIA

          -  Allergy or intolerance to heparin, aspirin, ADP receptor inhibitors
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fadi Al-Rashid, Dr.</last_name>
    <phone>00492017230</phone>
    <email>fadi.al-rashid@uk-essen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tienush Rassaf, Prof. Dr.</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Essen</name>
      <address>
        <city>Essen</city>
        <state>NRW</state>
        <zip>45122</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fadi Al-Rashid, Dr.med.</last_name>
      <phone>00492017230</phone>
      <email>fadi.al-rashid@uk-essen.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 3, 2017</study_first_submitted>
  <study_first_submitted_qc>July 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 11, 2017</study_first_posted>
  <last_update_submitted>May 15, 2018</last_update_submitted>
  <last_update_submitted_qc>May 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Essen</investigator_affiliation>
    <investigator_full_name>Fadi Al-Rashid</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

